Oric Pharmaceuticals, Inc.

ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001796280

Price chart

Open-market purchases and sales by ORIC insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 25, 20267:59 PM ETSep 24, 2026Piscitelli DominicChief Financial OfficerSSaleCommon Stock−600$13.5042−$8.1K69.83K−0.9%SEC10b5-1
Aug 28, 20264:11 PM ETAug 26, 2026Piscitelli DominicChief Financial OfficerSSaleCommon Stock−77K$13.6859−$1.05M69.83K−52.4%SEC10b5-1
Jul 28, 20264:15 PM ETJul 24, 2026Heyman Richard A.DirectorSSaleCommon Stock−7K$12.02−$84.14K38.3K−15.5%SEC10b5-1
Jul 28, 20264:15 PM ETJul 24, 2026Heyman Richard A.DirectorSSaleCommon Stock−6.1K$12.02−$73.32K206.67K−2.9%SEC10b5-1
Jul 8, 20264:35 PM ETJul 6, 2026Heyman Richard A.DirectorSSaleCommon Stock−300$12.00−$3.6K212.77K−0.1%SEC10b5-1

The largest institutional positions in ORIC at the end of Q2 2026.

Institutions holding ORIC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nextech Invest, Ltd.7,162,637$77.57M3.68%00.0%Unchanged
BlackRock, Inc.6,823,973$73.9M0.00%+839,421+14.0%Added
EcoR1 Capital, LLC6,728,116$72.87M3.61%00.0%Unchanged
PRICE T ROWE ASSOCIATES INC /MD/6,617,554$71.67M0.01%+1,229,771+22.8%Added
VIKING GLOBAL INVESTORS LPSuperinvestorViking Global Investors5,126,762$55.52M0.16%−697,771−12.0%Reduced